Targeting EphA3 Inhibits Cancer Growth by Disrupting the Tumor Stromal Microenvironment
Mary E Vail, Carmel Murone, April Tan, Linda Hii, Degu Abebe, Peter W Janes, Fook-Thean Lee, Mark Baer, Varghese Palath, Christopher Bebbington, Geoffrey Yarranton, Carmen Llerena, Slavisa Garic, David Abramson, Glenn Cartwright, Andrew M Scott, Martin Lackmann
Cancer Research | AMER ASSOC CANCER RESEARCH | Published : 2014
Awarded by NHMRC
Awarded by Prostrate Cancer Foundation Australia
This work was supported by grants from the NH&MRC (nos. 487922 and 1049942), Cancer Australia and Prostrate Cancer Foundation Australia (no. 491195; to M. Lackmann and A. M. Scott), The Human Frontiers Science Program (to M. Lackmann), funds from the Operational Infrastructure Support Program provided by the Victorian Government, Australia (to A. M. Scott), and KaloBios Pharmaceuticals (to M. Lackmann and A. M. Scott). M. Lackmann is an NH&MRC Senior Research Fellow.